http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-0306789-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8be6a6c990669567cc455d32b00535e |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57 |
| filingDate | 2003-01-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0041588da1b55410eb7be519abc5b71d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a142c764f085415b6c9cb68d672593ae |
| publicationDate | 2004-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-0306789-A |
| titleOfInvention | Tibolone use and method of treating estrogen deficiency complaints in female patients |
| abstract | "USE OF TIBOLONE AND METHOD OF TREATMENT OF COMPLAINTS RELATED TO ESTROGEN DEFICIENCY IN FEMALE SEX PATIENTS". A treatment of estrogen deficiency-related complaints in female subjects who exhibit these complaints while being treated with a drug that prevents endogenous estrogen synthesis is described. Such drugs are, e.g. anticancer drugs such as aromatase inhibitors. The invention resides in the use of tibolone, which has unexpectedly beneficial functioning in this particular patient group, in that it does not stimulate the breast while avoiding bone loss and alleviating climatic complaints in a patient group where this is more difficult than that in any other group, due to the nature of concomitant cancer treatment (no circulating estrogen resulting in a higher severity of complaints, the lack of effect on the estrogen receptor leading to an increased risk associated with estrogen stimulation of the breast, instead estrogen-like compounds are administered. |
| priorityDate | 2002-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444008 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536423 |
Total number of triples: 22.